Back
Speaker illustration

Mr Christopher Monkhouse

Barts Heart Centre, London (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology
European Heart Rythm Association

Presentations Articles

Evaluating subcutaneous implantable cardioverter defibrillators in hypertrophic cardiomyopathy: fewer complications without increased therapies

Event: EHRA 2025

Topic: Implantable Cardioverter-Defibrillator (ICD)

Session: Implantable cardioverter-defibrillator therapy

Access
Like
Thumbnail

Deprivation and device therapy: understanding the impact of socioeconomic status on ICD therapy outcomes

Event: EHRA 2025

Topic: Device Treatment

Session: Device therapy (2)

Access
Like
Thumbnail

long term follow up of Implantable Cardioverter Defibrillators (ICD) in hypertrophic cardiomyopathy: is subcutaneous the way forward?

Event: ESC Congress 2024

Topic: Implantable Cardioverter-Defibrillator (ICD)

Session: Subcutaneous and extravascular defibrillators: already mainstream?

Access
Like
Thumbnail

Optimising insertable cardiac monitors clinics: best practices and change management

Event: EHRA 2024

Topic: Implantable Loop Recorder

Session: Optimising insertable cardiac monitors clinics: best practices and change management

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources